Wednesday, November 5, 2014

Reminder by Oklahoma Board of Pharmacy: Compounders Beware Regarding DEA Regulations

♦ 13.32. Compounders Beware: All compounded products
that contain hydrocodone should be treated as Schedule II
drugs. This would require a hard copy prescription written
by the physician. Since these products are not Food and
Drug Administration (FDA) approved, Drug Enforcement
Administration (DEA) states that its rule is to go with the
higher schedule for the compound. The Code of Federal
Regulations that DEA operates under is based solely on
FDA approval
source 

No comments: